PortfolioPlus
Portfolio-Tracker – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
FIBROGEN Forum: Community User: NOK
Kommentare 212
Summer.76,
27.11.2020 13:13 Uhr
0
http://www.globenewswire.com/news-release/2020/11/27/2135245/0/en/Astellas-Receives-Approval-of-EVRENZO-roxadustat-in-Japan-for-the-Treatment-of-Anemia-of-Chronic-Kidney-Disease-in-Adult-Patients-Not-on-Dialysis.html
Summer.76,
05.11.2020 22:27 Uhr
0
FibroGen Reports Third Quarter 2020 Financial Results
https://www.globenewswire.com/news-release/2020/11/05/2121451/0/en/FibroGen-Reports-Third-Quarter-2020-Financial-Results.html
- Strong Third Quarter China Roxadustat Net Sales of $22.7 Million -
...
Summer.76,
03.11.2020 15:18 Uhr
0
https://pub.webull.com/us/news-html/2ed53ac64a2d4c70a7abbc5cb8a22fbf.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en&theme=1
FibroGen Inc (NASDAQ:FGEN) is a total spec and earnings won't matter, said Cramer. He likes the idea as long as investors put the stock in the total speculative column.
Summer.76,
22.10.2020 17:48 Uhr
0
https://www.globenewswire.com/news-release/2020/10/22/2112965/0/en/FibroGen-Presents-Late-Breaker-Abstract-Results-on-Associations-between-Hemoglobin-Levels-and-Cardiovascular-Outcomes-in-Roxadustat-Treated-Patients-with-Anemia-of-Chronic-Kidney-D.html
Summer.76,
03.09.2020 15:02 Uhr
0
https://endpts.com/akebia-shares-crater-as-their-phiii-anemia-drug-fails-on-safety-offering-rival-fibrogen-a-huge-advantage/
Akebia shares MACEd as their PhIII anemia drug fails on safety, offering rival FibroGen a huge advantage
Summer.76,
11.08.2020 17:25 Uhr
0
https://www.globenewswire.com/news-release/2020/08/11/2076245/0/en/FibroGen-Announces-First-Patient-Enrolled-in-Pamrevlumab-Phase-3-Clinical-Trial-in-Patients-with-Duchenne-Muscular-Dystrophy.html
Adler.,
07.08.2020 16:23 Uhr
0
Huiii ✌️
Summer.76,
07.08.2020 15:47 Uhr
0
*** = investing_
Summer.76,
07.08.2020 15:46 Uhr
0
Mizuho Securities Stick to Their Buy Rating for FibroGen
https://www.***/news/mizuho-securities-stick-to-their-buy-rating-for-fibrogen-2258082
...setting a price target of 72, which is approximately 68.82% above the present share price of 42.65.
...
Summer.76,
06.08.2020 22:48 Uhr
0
Bzw kurz:
https://seekingalpha.com/news/3602426-fibrogen-eps-misses-0_39-misses-on-revenue
FibroGen EPS misses by $0.39, misses on revenue
FibroGen (NASDAQ:FGEN): Q2 GAAP EPS of -$0.95 misses by $0.39.
Revenue of $42.89M (-77.6% Y/Y) misses by $5.4M.
Summer.76,
06.08.2020 22:43 Uhr
0
https://www.globenewswire.com/news-release/2020/08/06/2074568/0/en/FibroGen-Reports-Second-Quarter-2020-Financial-Results.html
FibroGen Reports Second Quarter 2020 Financial Results
Summer.76,
23.06.2020 15:11 Uhr
0
https://www.globenewswire.com/news-release/2020/06/23/2051872/0/en/FibroGen-Announces-First-Patient-Enrolled-in-Pamrevlumab-Clinical-Trial-in-Patients-Hospitalized-in-U-S-with-Acute-COVID-19.html
FibroGen gibt den ersten Patienten bekannt, der an einer klinischen Pamrevlumab-Studie bei Patienten mit akutem COVID-19 in den USA teilnimmt
Adler.,
22.06.2020 23:24 Uhr
0
👍👍👍
Summer.76,
22.06.2020 16:28 Uhr
0
http://www.globenewswire.com/news-release/2020/06/22/2051107/0/en/FibroGen-Appoints-Thane-Wettig-as-Chief-Commercial-Officer.html
Summer.76,
08.06.2020 15:22 Uhr
0
https://www.globenewswire.com/news-release/2020/06/08/2044807/0/en/FibroGen-Announces-First-Patient-Enrolled-in-Pamrevlumab-Clinical-Trial-in-Patients-Hospitalized-in-Italy-with-Severe-COVID-19.html
Adler.,
08.06.2020 14:18 Uhr
0
Yees ✌️
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | DRONESHIELD LTD Hauptdiskussion | +13,84 % | |
| 2 | TUI Hauptforum | +1,28 % | |
| 3 | CoinBase (Future ExChange) | +3,39 % | |
| 4 | INTUIT Hauptdiskussion | -13,32 % | |
| 5 | Goldpreis Hauptdiskussion | -0,10 % | |
| 6 | DEUTZ Hauptdiskussion | +10,71 % | |
| 7 | RENK (für normale, sachliche Kommunikation!) | +0,63 % | |
| 8 | Micron Neu | +3,05 % | |
| 9 | Atyr Pharma | +8,88 % | |
| 10 | OCCIDENTAL PETROLEUM Hauptdiskussion | -3,10 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | DRONESHIELD LTD Hauptdiskussion | +13,84 % | |
| 2 | TUI Hauptforum | +1,28 % | |
| 3 | CoinBase (Future ExChange) | +3,39 % | |
| 4 | INTUIT Hauptdiskussion | -13,32 % | |
| 5 | DEUTZ Hauptdiskussion | +10,71 % | |
| 6 | RENK (für normale, sachliche Kommunikation!) | +0,63 % | |
| 7 | Micron Neu | +3,05 % | |
| 8 | Atyr Pharma | +8,88 % | |
| 9 | OCCIDENTAL PETROLEUM Hauptdiskussion | -3,10 % | |
| 10 | Phunware 2025 | +3,37 % | Alle Diskussionen |